New Pure Play Novartis Vows To Up Its Game – With Help From In-House Challenger Ronny Gal

‘US First’ Policy To Boost Growth

 
• By Andrew McConaghie
  
Novartis
Novartis is shifting much of its clinical trial and commercial focus towards a 'US-first' approach to boost sales in the world's biggest market. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip